Publikationer 2014

Abugessaisa I, Saevarsdottir S, Tsipras G, et al. Accelerating translational research by clinically driven development of an informatics platform-a case study. PLoS One. 2014 Sep 9; 9(9):e104382.

Ajeganova S, Svensson B, Hafström I; BARFOT Study Group. Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomized trial. BMJ Open. 2014 Apr 7; 4(4):e004259.

Arkema EV, Feltelius N, et al.; on behalf of the ARTIS study group. No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment. Ann Rheum Dis. 2014 Aug 5.

Arkema EV, Jonsson J, Baecklund E, et al; on behalf of the ARTIS Study Group. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments? Ann Rheum Dis. 2014 Mar 7.

Bengtsson C, Padyukov L, Källberg H, et al. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study. Ann Rheum Dis. 2014 Jun; 73(6):1096-100.

Bossini-Castillo L, de Kovel C, Kallberg H, et al. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides. Ann Rheum Dis. 2014 Feb 14.

Brodin N, Lohela-Karlsson M, Swärdh E, et al. Cost-effectiveness of a one-year coaching program for healthy physical activity in early rheumatoid arthritis. Disabil Rehabil. 2014 Jul 14:1-6.

Chatzidionysiou K, Askling J, Eriksson J, et al; for the ARTIS group. Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register. Ann Rheum Dis. 2014 Jan 15.

Cui J, Taylor KE, Lee YC, et al. The influence of polygenic risk scores on heritability of anti-CCP level in RA. Genes Immun. 2014 Mar; 15(2):107-14.

Demmelmaier I, Lindkvist A, Nordgren B, et al. ”A gift from heaven” or ”This was not for me”. A mixed methods approach to describe experiences of participation in an outsourced physical activity program for persons with rheumatoid arthritis. Clin Rheumatol. 2014 Jun 20.

Emilsson L, Lindahl B, Köster M, et al. Review of 103 Swedish Healthcare Quality Registries. J Intern Med. 2014 Aug 31.

Eriksson JK, Karlsson JA, Bratt J, et al. Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial. Ann Rheum Dis. 2014 Apr 15.

Eriksson JK, Askling J, Arkema EV. The Swedish Rheumatology Quality Register: optimization of rheumatic disease assessments using register-enriched data. Clin Exp Rheumatol. 2014 Nov-Dec; 32 Suppl 85(5):147-149.

Frisell T, Hellgren K, Alfredsson L, et al. Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden. Ann Rheum Dis. 2014 Dec 12.

Hafström I, Engvall IL, Rönnelid J, et al. the BARFOT study group. Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study. BMJ Open. 2014 Jul 30; 4(7):e005246

Hallert E, Husberg M, Kalkan A, et al. Changes in sociodemographic characteristics at baseline in two Swedish cohorts of patients with early rheumatoid arthritis diagnosed 1996-98 and 2006-09. Scand J Rheumatol. 2014 Oct 29:1-6.

Hallert E, Husberg M, Kalkan A, et al. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project. Scand J Rheumatol. 2014; 43(3):177-83.

Hambardzumyan K, Bolce R, Saevarsdottir S, et al. RF pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Ann Rheum Dis. 2014 May 8.

Han B, Diogo D, Eyre S,et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet. 2014 Apr 3; 94(4):522-32.

Hellgren K, Smedby KE, Backlin C, et al. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Arthritis Rheumatol. 2014 May; 66(5):1282-90.

Innala L, Berglin E, Möller et al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2014 Apr 14; 16(2):R94.

Jiang X, Trouw LA, van Wesemael TJ, et al. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis. 2014 Oct; 73(10):1761-8.

Jiang X, Alfredsson L, Klareskog L, et al. Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: Results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) case-control study. Arthritis Care Res (Hoboken). 2014 Apr 9.

Jiang X, Frisell T, Askling J, et al. To which extent may the familial risk of rheumatoid arthritis be explained by established RA risk factors? Arthritis Rheumatol. 2014 Nov 24.

Ljung L, Askling J, Rantapää-Dahlqvist S, et al. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study. Arthritis Res Ther. 2014 Jun 18; 16(3):R127.

Kastbom A, Forslind K, Ernestam S, et al. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Ann Rheum Dis. 2014 Dec 30.

Kearsley-Fleet L, Závada J, Hetland ML,et al.; on behalf of the EULAR Study Group for Registers and Observational Drug Studies. The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers. Rheumatology (Oxford). 2014 Nov 27. 

Kobelt G. Treating to target with etanercept in rheumatoid arthritis: cost-effectiveness of dose reductions when remission is achieved. Value Health. 2014 Jul; 17(5):537-44.

Kristensen LE, Bliddal H, Christensen R, et al. Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort. Arthritis Care Res (Hoboken). 2014 Feb; 66(2):173-9.

Liu Y, Li X, Aryee MJ,et al. GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. Am J Hum Genet. 2014 Apr 3; 94(4):485-95.

Lööf H, Demmelmaier I, Henriksson EW, et al. Fear-avoidance beliefs about physical activity in adults with rheumatoid arthritis. Scand J Rheumatol. 2014 Sep 15:1-7.

Malm K, Bergman S, Andersson M, et al; the BARFOT study group. Predictors of severe self-reported disability in RA in a long-term follow-up study. Disabil Rehabil. 2014 Jul 18:1-6.

Nordgren B, Fridén C, Demmelmaier I, et al. Who makes it to the base? Selection procedure for a physical activity trial targeting people with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 May; 66(5):662-70.

Nordgren B, Fridén C, Jansson E, et al. Criterion validation of two submaximal aerobic fitness tests, the self-monitoring Fox-walk test and the Åstrand cycle test in people with rheumatoid arthritis. BMC Musculoskelet Disord. 2014 Sep 17; 15:305.

Nordgren B, Fridén C, Demmelmaier I, et al.; the PARA Study Group. An outsourced health-enhancing physical activity programme for people with rheumatoid arthritis: exploration of adherence and response. Rheumatology (Oxford). 2014 Nov 27.

Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014 Feb 20; 506 (7488):376-81.

Orellana C, Wedrén S, Källberg H, et al; EIRA Study Group. Parity and the risk of developing rheumatoid arthritis: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Ann Rheum Dis. 2014 Apr; 73(4):752-5.

Ostlund G, Björk M, Thyberg I, et al. Emotions related to participation restrictions as experienced by patients with early rheumatoid arthritis: a qualitative interview study (the Swedish TIRA project). Clin Rheumatol. 2014 May 17.

Raaschou P, Frisell T, Askling J; for the ARTIS Study Group. TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis. 2014 Aug 8.

Ruge T, Södergren A, Wållberg-Jonsson S et al. Circulating plasma levels of cathepsin S and L are not associated with disease severity in patients with rheumatoid arthritis. Scand J Rheumatol. 2014; 43(5):371-3.

Saevarsdottir S, Rezaei H, Geborek P, et al.; for the SWEFOT study group. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial. Ann Rheum Dis. 2014 Apr 4.

Sandberg ME, Bengtsson C, Källberg H, et al. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2014 May 12.

Sandberg ME, Wedrén S, Klareskog L, et al. Patients with regular physical activity before onset of rheumatoid arthritis present with milder disease. Ann Rheum Dis. 2014 Aug; 73(8):1541-4.

Sparks JA, Chen CY, Jiang X, et al. Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history. Ann Rheum Dis. 2014 Apr 30.

Theander E, Husmark T, Alenius GM,et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis. 2014 Feb; 73(2):407-13.

Thyberg M, Arvidsson P, Thyberg I, et al. Simplified bipartite concepts of functioning and disability recommended for interdisciplinary use of the ICF. Disabil Rehabil. 2014 Nov 3:1-10.

Wadström H, Eriksson J, Neovius M, et al., On Behalf Of The ARTIS Study Group.How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)? Scand J Rheumatol. 2014 Nov 7:1-7.

Wagner CA, Sokolove J, Lahey LJ, et al. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 ‘shared epitope’ alleles. Ann Rheum Dis. 2014 Jan 16.